Global Cardiology Academy

Welcome to Global
Cardiology Academy

Enhance your cardiology practice with CME and
tools focused on heart health management.

FINE-HEART Pooled Analysis
FINE-HEART Pooled Analysis
Cardiology
FINE-HEART Pooled Analysis
- Maria Pabon
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Cardiology
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
- Stefan D. Anker, MD, PhD
- Mahir Karakas, MD, PhD, MBA
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
Cardiology
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
- Akshay S. Desai, MD
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
Cardiology
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
- Jonathan Cunningham, MD
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
Heart Matters
Complexities in ATTR-CM Care: Key Considerations for Accurate Diagnosis
- Gautam Nayak, MD
Addressing Unmet Needs in ATTR-CM Care: Key Considerations for Optimal Management
Addressing Unmet Needs in ATTR-CM Care: Key Considerations for Optimal Management
Heart Matters
Addressing Unmet Needs in ATTR-CM Care: Key Considerations for Optimal Management
- Michelle Kittleson, MD, PhD
Understanding the Pathophysiology Behind ATTR-CM
Understanding the Pathophysiology Behind ATTR-CM
Heart Matters
Understanding the Pathophysiology Behind ATTR-CM
- Frederick Ruberg, MD
ATTR-CM Screening: How Economic Factors Can Impact Care
ATTR-CM Screening: How Economic Factors Can Impact Care
Heart Matters
ATTR-CM Screening: How Economic Factors Can Impact Care
- Kibum Kim, PhD

Programs

Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
CME/CE
Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
1.00 credit
- Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
- Rishi Wadhera, MD, MPP, Mphil
1.00 credit
Case Consult: Adverse Effect Monitoring, Management, and Mitigation During Targeted Therapy for BRAF-Mutant mCRC
Case Consult: Adverse Effect Monitoring, Management, and Mitigation During Targeted Therapy for BRAF-Mutant mCRC
MinuteCE®
Case Consult: Adverse Effect Monitoring, Management, and Mitigation During Targeted Therapy for BRAF-Mutant mCRC
1.00 program credit
- Fortunato Ciardiello, MD, PhD
- Jenny Seligmann, MBChB, PhD
1.00 program credit
Treating ATTR-CM: Current Strategies and Emerging Options
Treating ATTR-CM: Current Strategies and Emerging Options
Heart Matters
Treating ATTR-CM: Current Strategies and Emerging Options
- Frederick Ruberg, MD
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
MinuteCE®
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Valeria Caso, MD, PhD
1.00 program credit
Patient Case Study: Elderly
Patient Case Study: Elderly
MinuteCE®
Patient Case Study: Elderly
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Valeria Caso, MD, PhD
1.00 program credit
Managing Patients With AAV in the Rheumatology Clinic
Managing Patients With AAV in the Rheumatology Clinic
MinuteCE®
Managing Patients With AAV in the Rheumatology Clinic
0.75 program credits
- Andreas Kronbichler, MD
- Bernhard Hellmich, MD
0.75 program credits
Trade off: Ischemic/Thrombotic vs Bleeding  
Trade off: Ischemic/Thrombotic vs Bleeding  
MinuteCE®
Trade off: Ischemic/Thrombotic vs Bleeding  
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
1.00 program credit
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Tailoring Treatment for Optimal Outcomes in Patients With AAV
MinuteCE®
Tailoring Treatment for Optimal Outcomes in Patients With AAV
0.75 program credits
- Bernhard Hellmich, MD
- Andreas Kronbichler, MD
0.75 program credits

Clinical Practice

Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
Cardiology
Analysis of Patients With and Without AF Living With HFmrEF/HFpEF: FINEARTS-HF
- Akshay S. Desai, MD
NYHA FC and Finerenone Response: Clinical Trial Insights
NYHA FC and Finerenone Response: Clinical Trial Insights
Cardiology
NYHA FC and Finerenone Response: Clinical Trial Insights
- John Ostrominski
Advances in Care for ATTR-CM: Current and Emerging Strategies
Advances in Care for ATTR-CM: Current and Emerging Strategies
Heart Matters
Advances in Care for ATTR-CM: Current and Emerging Strategies
- Gautam Nayak, MD
Overcoming Challenges in ATTR-CM Care: Best Practices for Accurate Diagnosis
Overcoming Challenges in ATTR-CM Care: Best Practices for Accurate Diagnosis
Heart Matters
Overcoming Challenges in ATTR-CM Care: Best Practices for Accurate Diagnosis
- Michelle Kittleson, MD, PhD
Don't Miss It! Rapid & Accurate AAV Diagnosis 
Don't Miss It! Rapid & Accurate AAV Diagnosis 
MinuteCE®
Don't Miss It! Rapid & Accurate AAV Diagnosis 
0.75 program credits
- Silke R. Brix, MD, MRCP, SCPR
- Andreas Kronbichler, MD
0.75 program credits
Optimizing AAV Outcomes: Maintenance Therapies
Optimizing AAV Outcomes: Maintenance Therapies
MinuteCE®
Optimizing AAV Outcomes: Maintenance Therapies
0.75 program credits
- Bernhard Hellmich, MD
- Silke R. Brix, MD, MRCP, SCPR
0.75 program credits
Elevating Care for Patients With Severe Renal Disease in AAV
Elevating Care for Patients With Severe Renal Disease in AAV
MinuteCE®
Elevating Care for Patients With Severe Renal Disease in AAV
0.75 program credits
- Silke R. Brix, MD, MRCP, SCPR
- Andreas Kronbichler, MD
0.75 program credits
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
MinuteCE®
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
1.00 program credit
- Valeria Caso, MD, PhD
1.00 program credit

CME

Patient Case Study: Obesity
Patient Case Study: Obesity
MinuteCE®
Patient Case Study: Obesity
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Valeria Caso, MD, PhD
1.00 program credit
Setting the Stage of Real-World Data vs RCT
Setting the Stage of Real-World Data vs RCT
MinuteCE®
Setting the Stage of Real-World Data vs RCT
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
1.00 program credit
Implementing the SOC Induction Therapies in AAV 
Implementing the SOC Induction Therapies in AAV 
MinuteCE®
Implementing the SOC Induction Therapies in AAV 
0.75 program credits
- Silke R. Brix, MD, MRCP, SCPR
- Bernhard Hellmich, MD
0.75 program credits
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
MinuteCE®
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
1.00 program credit
- Alexander T. Cohen, MD, MBBS
1.00 program credit
Patient Case Study: Obesity and VTE
Patient Case Study: Obesity and VTE
MinuteCE®
Patient Case Study: Obesity and VTE
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Alexander T. Cohen, MD, MBBS
1.00 program credit
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
CME/CE
Best Practices for Identifying, Diagnosing and Treating Transthyretin Amyloidosis (ATTR-PN and ATTR-CM)
0.50 credits
- John Russell, MD
- Noel Dasgupta, MD, FACC
- Sami Khella, MD
0.50 credits
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
CME/CE
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
0.50 credits
- Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
- Scott Solomon, MD
- Mikhail Kosiborod, MD
0.50 credits
A Practical Guide to Prescribing in HF
A Practical Guide to Prescribing in HF
MinuteCE®
A Practical Guide to Prescribing in HF
0.75 program credits
- Neil Skolnik, MD
- Barry Greenberg, MD
- Trina Huynh, PharmD
- Melissa Mclenon, DNP, ACNP-BC
0.75 program credits